Selective screening of secretory vesicle-associated proteins for autoantigens in type 1 diabetes: VAMP2 and NPY are new minor autoantigens

This publication has 45 references indexed in Scilit:

• The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
  Proceedings of the National Academy of Sciences, 2007
• No evidence of diabetes-specific CD38 (ADP ribosil cyclase/cyclic ADP-ribose hydrolase) autoantibodies by liquid-phase immunoprecipitation
  Diabetic Medicine, 2005
• Autoantibodies to REG, a beta‐cell regeneration factor, in diabetic patients
  European Journal of Clinical Investigation, 2004
• Autoantibodies against IA-2, GAD, and topoisomerase II in type 1 diabetic patients
  Biochemical and Biophysical Research Communications, 2004
• Increased Autoantibodies to SOX13 in Swedish Patients with Type 1 Diabetes
  Annals of the New York Academy of Sciences, 2002
• Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group.
  Journal of Clinical Investigation, 1998
• Autoantibodies to the GM2-1 Islet Ganglioside and to GAD-65 at Type 1 Diabetes Onset
  Journal of Autoimmunity, 1997
• Autoantigenic Properties of Native and Denatured Glutamic Acid Decarboxylase: Evidence for a Conformational Epitope
  Clinical Immunology and Immunopathology, 1994
• Transcription factor jun-B is target of autoreactive T-cells in IDDM
  Diabetes, 1993
• A 64 kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: Co-precipitation with a 38 kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes
  Journal of Autoimmunity, 1992